Emmaus Life Sciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Emmaus Life Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Emmaus Life Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.72M, a 31.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.72M -$791K -31.5% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $1.9M -$682K -26.4% Jun 30, 2024 10-Q 2024-09-10
Q1 2024 $2.08M -$564K -21.3% Mar 31, 2024 10-Q 2024-09-10
Q4 2023 $2.34M -$462K -16.5% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 $2.51M -$434K -14.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.59M -$500K -16.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.65M -$672K -20.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.8M -$686K -19.7% Dec 31, 2022 10-K 2024-07-03
Q3 2022 $2.94M -$698K -19.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.09M -$711K -18.7% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $3.32M -$629K -15.9% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $3.49M -$587K -14.4% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.64M -$503K -12.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $3.8M -$487K -11.4% Jun 30, 2021 10-Q 2021-09-01
Q1 2021 $3.95M -$397K -9.14% Mar 31, 2021 10-Q 2021-09-01
Q4 2020 $4.07M -$402K -8.99% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $4.15M +$27K +0.66% Sep 30, 2020 10-Q 2021-08-26
Q2 2020 $4.28M -$2K -0.05% Jun 30, 2020 10-Q 2021-08-26
Q1 2020 $4.34M +$1.51M +53.1% Mar 31, 2020 10-Q 2021-08-26
Q4 2019 $4.47M Dec 31, 2019 10-Q 2021-08-26
Q3 2019 $4.12M Sep 30, 2019 10-K 2021-01-25
Q2 2019 $4.29M Jun 30, 2019 10-Q 2021-08-26
Q1 2019 $2.84M Mar 31, 2019 10-Q 2021-08-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.